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Abstract
 
Interstitial fluid is constantly drained into lymph nodes (LNs) via afferent lymph vessels. This
conduit enables monocyte-derived macrophages and dendritic cells to access LNs from periph-
eral tissues. We show that during inflammation in the skin, a second recruitment pathway is
evoked that recruits large numbers of blood-borne monocytes to LNs via high endothelial
venules (HEVs). Inhibition of monocyte chemoattractant protein (MCP)-1 blocked this in-
flammation-induced monocyte homing to LNs. MCP-1 mRNA in inflamed skin was over
100-fold upregulated and paralleled MCP-1 protein levels, whereas in draining LNs MCP-1
mRNA induction was much weaker and occurred only after a pronounced rise in MCP-1 pro-
tein. Thus, MCP-1 in draining LNs was primarily derived from inflamed skin. In MCP-1
 
 
 
/
 
 
 
mice, intracutaneously injected MCP-1 accumulated rapidly in the draining LNs where it en-
hanced monocyte recruitment. Intravital microscopy showed that skin-derived MCP-1 was
transported via the lymph to the luminal surface of HEVs where it triggered integrin-depen-
dent arrest of rolling monocytes. These findings demonstrate that inflamed peripheral tissues
project their local chemokine profile to HEVs in draining LNs and thereby exert “remote con-
trol” over the composition of leukocyte populations that home to these organs from the blood.
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Introduction
 
Blood-borne monocytes possess developmental plasticity
allowing them to differentiate into macrophages or subsets
of dendritic cells (DCs)
 
*
 
 upon entering tissues. These two
monocyte-derived cell types perform crucial immune func-
tions, particularly in peripheral LNs (PLNs). How mono-
cytes and their descendants enter PLNs is incompletely un-
derstood. Some monocytes exit the blood at peripheral sites
of inflammation, load themselves with antigen, and be-
come mature antigen-presenting DCs during their transit
to draining PLNs via afferent lymphatics (1). Tissue resi-
dent macrophages, dermal DCs, and Langerhans cells enter
PLNs by the same route (2, 3). Some mechanisms by
which monocyte-derived cells enter PLNs via the lymph
have been uncovered recently (1, 4, 5). In addition, mono-
cytes may enter PLNs directly from the blood through high
endothelial venules (HEVs), the route taken by naive lym-
phocytes and subsets of memory cells (6, 7). Classic elec-
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tron microscopy studies have suggested that monocyte
homing via HEVs may be induced by unknown signals in
PLNs that drain inflamed tissues. In resting PLNs, macro-
phages reside mostly in subcapsular and medullary sinuses
distant from HEVs, but in inflamed PLNs monocytes/mac-
rophages were detected within and around HEVs (8).
Consistent with this concept, the monocyte cell line
WEHI78/24 was found to adhere in an integrin-dependent
fashion to HEVs in frozen sections of inflamed, but not
resting PLNs (9). However, the magnitude, kinetics, and
mechanisms by which monocytes home to inflamed PLNs
via HEVs have not been explored in vivo.
Since monocyte-expressed integrins are likely to play a
role (9) and since these molecules must be activated for ef-
ficient binding to endothelial cells, we hypothesized that
inflamed HEVs display chemoattractants that trigger inte-
grin activation on intravascular monocytes. One candidate
molecule is the inflammatory CC chemokine monocyte
chemotactic protein (MCP)-1 (CCL2), which regulates
monocyte recruitment from blood into many nonlym-
phoid tissues (10). In vitro, MCP-1 stimulates arrest of roll-
ing human monocytes under flow (11) and also promotes
transendothelial migration (12). In addition, MCP-1 has
been implicated in angiogenesis (13, 14), maintenance of
Th2-lymphocyte populations (15), and modulation of
HIV-1 infection of mononuclear cells (16).
Chemokines are commonly thought to act locally, di-
recting leukocyte migration into and within the tissue in
which they are generated. However, previous observations
suggest a mechanism by which chemokines may act far
away from the site of their origin (17, 18). In this paradigm,
chemokines use the afferent lymphatics, and the fibroblastic
reticular cell (FRC) network within draining PLNs, as
conduits for transport from peripheral tissues to HEVs (17,
18). However, these earlier studies have examined the fate
of relatively large quantities of recombinant chemokines af-
ter bolus injection into the skin. The question whether en-
dogenous chemokines are transported from peripheral tis-
sues to draining LNs and how this would affect the nodal
environment has not been addressed.
Here we show that a remotely generated chemokine
plays a profound role in PLNs that drain inflamed skin.
Circulating monocytes are recruited into such PLNs by
MCP-1, which is rapidly released in inflamed skin, trans-
ported via the lymph into PLNs, and translocated to the
luminal surface of HEVs. Intravascular MCP-1 then acti-
vates CCR2 on rolling monocytes, which triggers inte-
grin-mediated arrest. These observations suggest a mecha-
nism by which multistep adhesion cascades in HEVs can be
modulated remotely, thus enabling peripheral tissues to
control the composition and function of leukocytes in the
draining LNs.
 
Materials and Methods
 
Animals.
 
Mice were used in accordance with NIH guide-
lines, in experiments approved by the Institutional Review Com-
mittees of Harvard Medical School and the Center for Blood Re-
search. MCP-1
 
 
 
/
 
 
 
 mice on C57BL/6 background (19) and
CX3CR1
 
 
 
/GFP
 
 mice on C57 
 
 
 
 129Sv background (20) were
bred in a specific pathogen-free, viral antibody-free (SPF/VAF)
barrier facility. Wild-type C57BL/6 mice were from The Jackson
Laboratory. All mice tested negative for specific pathogens and
were kept on sterile bedding with unrestricted access to auto-
claved water and lab chow.
 
Induction of Cutaneous Inflammation.
 
Equal volumes of com-
plete Freund’s adjuvant (CFA) and sterile PBS containing key-
hole limpet hemocyanin (KLH; final concentration 2.5 mg/ml)
were emulsified (CFA/KLH). Mice were anaesthetized with ket-
amine and xylazine, and 50 
 
 
 
l of the CFA/KLH emulsion was
injected intracutaneously over one or both flanks or the upper
right lateral thorax. At various time points thereafter the injection
site and draining PLNs were removed for histology or analysis of
cellular composition, MCP-1 protein, and mRNA levels. In
some experiments draining subiliac PLNs were prepared for ob-
servation by intravital microscopy (21).
For enumeration of the number of CD11b
 
 
 
F4/80
 
 
 
 leuko-
cytes, PLNs were removed, digested in type II collagenase (0.5%
wt/vol in HBSS, 37
 
 
 
C, 40 min; Worthington Biochemical) and
stained with anti–CD45-PE (Ly-5; BD PharMingen), anti–
CD11b-FITC (M1/70; BD PharMingen), and biotinylated mAb
F4/80 (Serotec), followed by streptavidin-CyChrome, and ana-
lyzed on a flow cytometer (FACscan™; Becton Dickinson). To
determine the total number of leukocytes, a known number of
PKH26-labeled microspheres (Sigma-Aldrich) were added to
each sample.
 
Adoptive Transfer Homing Assays Using CX3CR1
 
 
 
/GFP
 
 Leuko-
cytes.
 
For each experiment, blood was obtained from 
 
 
 
50 do-
nor CX3CR1
 
 
 
/GFP
 
 mice by cardiac puncture and PBMCs were
isolated using Histopaque 1083 (Sigma-Aldrich). For phenotypic
analysis aliquots of PBMCs were stained with mAb as described
previously, and with rabbit polyclonal anti-CCR2 Ab. 5 
 
 
 
 10
 
6
 
CX3CR1
 
 
 
/GFP
 
 PBMCs, which contained 
 
 
 
10% cells that ex-
pressed detectable levels of green fluorescent protein (GFP), were
warmed to 37
 
 
 
C and then injected intravenously into recipient
animals 5–7 d after inducing unilateral cutaneous inflammation.
Recipient mice were pretreated with anti–MCP-1 (2H5; BD
PharMingen) or isotype control mAb (G235–2356; BD Phar-
Mingen; 25 
 
 
 
g intraperitoneally at 
 
 
 
2 h and 25 
 
 
 
g intravenously
at 
 
 
 
20 min). To compare the magnitude of monocyte recruit-
ment to a well-characterized LN-tropic reference population,
five mice with 5-d-old skin inflammation received 5 
 
 
 
 10
 
6
 
 LN
cells (containing 
 
 
 
75% GFP
 
 
 
 naive T cells) from T-GFP mice
(17). 4 h after injection of donor CX3CR
 
 
 
/GFP
 
 PBMCs or T
 
GFP
 
LN cells, mice were killed, a blood sample was taken by cardiac
puncture, and the spleen, draining, and contralateral PLNs were
removed and digested in collagenase. Samples were stained with
anti–NK1.1-PE (NKR-P1C; BD PharMingen) and anti–CD45-
CyChrome and GFP
 
 
 
CD45
 
 
 
NK1.1
 
 
 
 cells were counted by
flow cytometry.
 
Analysis of CX3CR1
 
 
 
/GFP
 
 Leukocyte Homing To Inflamed PLNs
by Confocal Microscopy.
 
5 d after intracutaneous injection of
CFA/KLH in the flank skin of six wild-type mice, three animals
received an intravenous injection of 5 
 
 
 
 10
 
6
 
 CX3CR1
 
 
 
/GFP
 
PBMCs (
 
 
 
5 
 
 
 
 10
 
5
 
 GFP
 
 
 
 cells), while the other three mice were
injected into the skin granuloma with CX3CR1
 
 
 
/GFP
 
 PBMCs
containing 2.5 
 
 
 
 10
 
5
 
 GFP
 
 
 
 cells. The draining subiliac LNs were
harvested after 1 h, frozen in OCT, and 20-
 
 
 
m thick sections
were stained with anti-PNAd mAb MECA-79 followed by Cy5-
anti–rat IgM. GFP
 
 
 
 leukocytes were classified according to their
position relative to the nearest MECA-79
 
 
 
 vessel using confocal 
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microscopy (Olympus BX50WI; BioRad Radiance 2000 scan-
head).
 
Reconstitution of CX3CR1
 
 
 
/GFP
 
 Leukocyte Homing in MCP-1–
deficient Mice.
 
MCP-1
 
 
 
/
 
 
 
 mice were injected intracutaneously
with CFA/KLH over both flanks and the upper right lateral tho-
rax. On day 5, animals were injected into the inflamed skin with
recombinant murine MCP-1 (25 
 
 
 
g in 50 
 
 
 
l PBS) over the left
subiliac LN and with vehicle alone (50 
 
 
 
l PBS) over the right
subiliac and brachial LNs. 10 min later, all animals received 1.5 
 
 
 
10
 
7
 
 CX3CR1
 
 
 
/GFP
 
 PBMCs intravenously. Both subiliac LNs and
the right brachial LN were harvested 90 min after cell injection
for quantification of GFP
 
 
 
 cells by flow cytometry. To determine
the distribution of intracutaneously injected MCP-1 in draining
and contralateral PLNs, three additional MCP-1
 
 
 
/
 
 
 
 mice were
injected with CFA/KLH and, on day 5, with 25 
 
 
 
g MCP-1 and
vehicle as described previously. One control animal received
CFA/KLH, but no chemokine. Both subiliac LNs and the in-
flamed brachial LNs were removed 90 min after injection and
prepared for ELISA. Readings from the control animal were used
to subtract unspecific background signals for each organ.
 
Murine MCP-1 ELISA.
 
For studies on endogenous MCP-1
protein concentration in inflamed tissues, CFA/KLH cutaneous
injection sites and draining subiliac PLNs were removed from
killed wild-type mice, weighed, homogenized in lysis buffer (PBS
with 1 mM PMSF, 0.01 mg/ml aprotonin, and 0.01 mg/ml leu-
peptin), sonicated, and centrifuged (14,000
 
 
 
 
 
g
 
 at 4
 
 
 
C for 20
min). The supernatant was assayed for MCP-1 immunoreactivity
by ELISA (Quantikine; R&D Systems). The same approach was
taken to assess MCP-1 concentration in PLN of MCP-1
 
 
 
/
 
 
 
 mice
after intracutaneous injection of chemokine or PBS.
 
Intravital Microscopy of the Subiliac PLNs.
 
The left or right
subiliac PLN was prepared for viewing by intravital microscopy
as described previously (21). In some experiments, PLNs were in-
flamed by intracutaneous injection of CFA/KLH into the flank
3–7 d before observation.
 
Observation of WEHI78/24 Cells in the Subiliac PLN Microvascu-
lature.
 
Calcein-labeled WEHI78/24 cells were injected through
a femoral artery catheter and visualized in the downstream PLN
microvasculature as described previously (21). PLN venules were
classified based on their branching order ranging from I-V, where
the order I venule is the large hilar collecting venule that drains
blood out of the PLN and higher order venules are successively
smaller branches upstream (21). Within each venule, WEHI78/
24 cells were classified as rolling (cells obviously interacting with
the vessel wall, with a slower velocity than the blood stream) or
noninteracting. The rolling fraction was calculated as the percent-
age of rolling cells in the total number of cells entering the
venule. Cells that arrested on the vessel wall for at least 30 s were
classified as sticking cells. The sticking fraction was calculated as
the percentage of arrested cells in the total number of rolling cells.
In some experiments where observation times were limited by
the number of cells that could be injected (to enable multiple in-
jections of differently treated cells), only higher order (IV-V) ves-
sels were analyzed, because homing occurs primarily in these sub-
cortical branches (21).
 
Observation of Intracutaneously Injected MCP-1 in the Draining
PLN.
 
Human MCP-1 was synthesized with an Alexa
 
565
 
-conju-
gated 6
 
 
 
Histidine tag at the COOH terminus (Alexa-conjugated
human MCP-1 
 
[
 
hMCP-1
 
ALEXA
 
]). hMCP-1
 
ALEXA
 
 (0.5 
 
 
 
g/injec-
tion site) was injected intracutaneously 40 min before preparation
of the draining PLN for epifluorescence intravital microscopy. At
the end of the observation period the PLN vasculature was visual-
ized with intravenous FITC-dextran (mol. wt. 150 KD; Sigma-
Aldrich). In some experiments, 
 
125
 
I-labeled human MCP-1 (250
 
 
 
Ci/
 
 
 
g protein, 1.3 ng/injection site) was injected intracutane-
ously into recipient mice. 1 h later, the draining PLNs were re-
moved and prepared for autoradiography and immunohistology
as described previously (22).
 
Analysis of Murine MCP-1 mRNA Using Real-Time PCR (Taq-
Man
 
®
 
).
 
The CFA/KLH injection site (50–100 mg) and drain-
ing PLNs were flash frozen in liquid N2. Total RNA was
extracted with the ULTRASPEC-II RNA Isolation System
(BioTecx Laboratories) and mRNA from 100 
 
 
 
g total RNA was
purified using a QIAGEN Oligotex mRNA kit (QIAGEN).
cDNA was synthesized using mRNA equivalent to 
 
 
 
30 
 
 
 
g total
RNA. Multiplex Real Time Quantitative mRNA analyses were
performed in an ABI Prism 7700 Sequence Detection System us-
ing FAM-labeled MCP-1 and VIC-labeled GAPDH probes and
appropriate primers (PE Applied Biosystems). 
 
 
 
C
 
T
 
 values (MCP-1
C
 
T
 
 minus GAPDH C
 
T
 
) for each triplicate sample were averaged
and 
 
  
 
C
 
T
 
 was calculated as follows: 
 
 
 
C
 
T
 
 values from the control
group (t 
 
 
 
 0 h) were averaged and subtracted from 
 
 
 
C
 
T
 
 values of
individual mice. mRNA amplification was determined by the
formula 2
 
-
 
  
 
CT
 
.
 
Statistical Analysis.
 
Data are presented as mean   SEM. The
Student’s t test was used for comparison of two groups. One-
way ANOVA followed by Dunnett’s test was used for compari-
son of multiple test groups with a control group. P   0.05 was
considered significant.
Results
Cutaneous Inflammation Stimulates Monocyte/Macrophage
Accumulation in Draining PLNs. To examine monocyte
recruitment to reactive PLNs and to dissect the underlying
molecular mechanisms we injected CFA/KLH into the
flank skin, an approach previously shown to induce a
strong local inflammatory response that alters the physiol-
ogy of draining PLNs (23, 24). We analyzed the number of
mononuclear phagocytes (CD11b F4/80 , reference 25)
in the inflamed (i.e., ipsilateral) and the contralateral subil-
iac LNs (also called superficial inguinal LNs) at various
times thereafter (Fig. 1 A). A small, but statistically signifi-
cant increase in CD11b F4/80  leukocytes was seen in in-
flamed PLNs as early as 24 h after CFA/KLH injection. A
much more dramatic rise was observed on days 3 and 7. In
contrast, monocyte numbers remained low in the con-
tralateral PLNs. This indicates that intracutaneous injection
of CFA/KLH did not alter systemic monocyte behavior,
but exerted its effects only at the injection site and in ana-
tomically connected PLNs. It is possible that some of the
injected CFA/KLH became lymph-borne and exerted lo-
cal responses in the draining PLNs. However, as will be
shown below, the dramatic effect of CFA/KLH on mono-
cyte accumulation in draining PLNs was mainly due to
continuous release of secondary mediators from inflamed
skin into the lymph.
MCP-1 Mediates Mononuclear Phagocyte Recruitment to
Inflamed PLNs. Since several studies have shown that
MCP-1 (CCL2) is a key regulator of monocyte recruit-
ment to sites of inflammation (19, 26), we studied the role
of this chemokine in our model. Injection of CFA/KLH
into the skin of MCP-1 /  mice resulted in markedly di-1364 Chemokine Action by Remote Control
minished recruitment of CD11b F4/80  leukocytes in
draining PLNs (Fig. 1 A). Unlike in wild-type PLNs,
monocyte numbers in ipsi and contralateral subiliac LNs of
MCP-1 /  mice did not differ significantly at day 1. When
compared with wild-type PLNs, monocyte numbers in
draining MCP-1 /  PLNs were reduced on days 1 and 3
by 48 and 54%, respectively, but this difference did not
reach statistical significance. At day 7, 78% fewer mono-
cytes were found than in wild-type PLNs (P   0.01). Sim-
ilar results were obtained using mice deficient in the MCP-1
receptor, CCR2 (data not shown).
The Site of Inflammation, not the Draining PLN Is the Major
Source of MCP-1. Having determined that MCP-1 is a
crucial mediator of monocyte accumulation in PLNs drain-
ing inflamed skin, we set out to localize the source(s) of this
chemokine. MCP-1 protein was measured by ELISA, and
MCP-1 mRNA levels were quantified using real-time
RT-PCR (TaqMan®; Applied Biosystems) in tissue ho-
mogenates from the injection site and the draining subiliac
LN. Very low MCP-1 protein levels were detected in nor-
mal tissues (Fig. 1 B). Upon injection of CFA/KLH,
MCP-1 protein levels in the skin increased to a maximum
that was 43-fold higher than baseline levels as early as 3 h
after injection, and they remained markedly elevated for
the 7-d duration of the experiment. In contrast, in the
draining PLN MCP-1 protein levels did not change signif-
icantly until 6 h after CFA/KLH injection, when a fivefold
increase over preinjection levels was measured. A peak sev-
enfold increase was observed in draining PLNs at 12 h, and
MCP-1 protein levels plateaued thereafter.
MCP-1 mRNA in the injection site increased 17-fold
over preinjection levels within 3 h after CFA/KLH injec-
tion, reached a maximal 200-fold increase at 12 h, and re-
mained elevated throughout the 1 wk experiment (Fig. 1
C). Interestingly, although MCP-1 protein was increased
in the draining PLN at 6 h, MCP-1 mRNA expression did
not exceed baseline levels in that organ until 12 h after
CFA/KLH injection. At this time, a modest threefold in-
crease was measured, which steadily declined during the
following days. Thus, at the site of inflammation a dramatic
rise in MCP-1 protein was paralleled by an increase in
MCP-1 mRNA, whereas in draining PLNs the increase in
MCP-1 protein preceded the induction of MCP-1
mRNA, which was subtle and transient. These results sug-
gest that the inflamed skin was the predominant source of
MCP-1, and that MCP-1 produced at the site of inflamma-
tion may be transported to the draining PLN.
MCP-1 Mediates Monocyte Homing to Inflamed PLNs.
Blood-borne monocytes may access PLNs either via afferent
lymph after leaving the circulation in inflamed peripheral
tissues (1) or directly via HEVs (27). Since MCP-1 was ex-
pressed in both locations after CFA/KLH injection, we in-
vestigated which route was taken by monocytes in our
model. To this end, we isolated PBMCs from heterozygous
CX3CR1 /GFP knockin mice in which a cDNA for GFP
was targeted to the CX3CR1 locus. Among CX3CR1 /GFP
PBMCs, only monocytes and a small subset of NK cells ex-
press GFP (20). A further analysis of CX3CR1 /GFP PBMC
(which constitute  1–3% of circulating leukocytes in
CX3CR /GFP mice) showed that 86% of GFP  leukocytes
expressed F4/80, and 96% were CD11bHIGH (Fig. 2 A).
Two subsets of CD11bHIGHGFP  leukocytes were apparent
Figure 1. Rapid, sustained induction of MCP-1 in inflamed skin pre-
cipitates monocyte/macrophage accumulation in draining PLNs. (A)
Time course of monocyte/macrophage recruitment to PLNs of wild-type
and MCP-1 /  mice. CD11b F4/80  leukocytes were counted in subil-
iac PLNs at different times after intracutaneous injection of CFA/KLH
into the ipsilateral flank. Monocyte numbers in the contralateral, nonin-
flamed subiliac PLNs are shown for comparison. †P   0.05; ††P   0.01 vs.
wild-type inflamed; *P   0.01 MCP-1 /  vs. wild-type; #P   0.05 vs.
MCP-1 /  inflamed. n   3–6 mice per group. (B) Time course of MCP-1
immunoreactivity in lysates of cutaneous sites of CFA/KLH injection ( )
and the draining subiliac PLNs ( ) measured by ELISA. *P   0.05;
**P   0.01 vs. noninflamed tissue. n   6. (C) Time course of MCP-1
mRNA expression in the CFA/KLH-inflamed subiliac PLN ( ) and skin
injection site ( ). Fold change in MCP-1 mRNA levels over preinjection
expression was measured in triplicate samples by real-time RT-PCR
(TaqMan®) as described in Materials and Methods. Note that at 6 h (bro-
ken line in B and C), MCP-1 protein levels in draining PLNs were signif-
icantly increased above baseline, whereas mRNA levels were not. n   3–6
mice per group. Symbols and bars represent mean   SEM.1365 Palframan et al.
based on their differential expression of CCR2 and L-selec-
tin (CD62L), which were only found on GFPMED cells,
while most GFPHIGH cells were CCR2  and L-selectin .
Accordingly, only the GFPMED leukocytes migrated toward
MCP-1 in chemotaxis assays (data not shown). Thus, there
are at least two F4/80 CD11b  mononuclear subsets in
murine blood. Considering their surface phenotype, it
seems likely that the CCR2 CD62L F4/80 CD11b 
GFPMED population represents bona fide monocytes. Of
note, these cells did not respond to the CCR7 agonist sec-
ondary lymphoid tissue chemokine (SLC; also called TCA-4,
6-C-kine, exodus 2, CCL21), which is constitutively ex-
pressed in HEVs and mediates T cell homing to PLNs (ref-
erences 17 and 28, and data not shown).
Initially, we set out to determine whether GFP expres-
sion is retained in monocytes/macrophages that accumu-
late in inflamed PLNs of CX3CR /GFP mice. 5 d after in-
duction of skin inflammation in three animals, 88   3% of
the F4/80 CD11b  cells in inflamed PLNs expressed
GFP, and nearly all of these were GFPMED (data not
shown). This suggested that CX3CR1 /GFP PBMCs may
be a useful tool to study whether and by what route mono-
cytes home to inflamed PLNs. Thus, short-term homing
experiments were performed by intravenous injection of
CX3CR1 /GFP PBMCs into wild-type recipient mice 5–7 d
after intracutaneous injection of CFA/KLH. 4 h later, a
marked increase in homed NK1.1–GFP  monocytes was
observed in inflamed PLNs compared with contralateral
PLNs in animals receiving a control mAb. The GFPMED
monocytes constituted the majority (83%) of homed GFP 
cells in PLNs, while their mean frequency in the recipi-
ents’ blood (45%) was significantly lower than in the input
(62%) indicating that the CD62L CD11b CCR2  subset
is preferentially recruited to inflamed PLNs (Fig. 2 B and
C). Consistent with the idea that CCR2/MCP-1 is re-
quired for inflammation-induced homing, concomitant in-
jection of anti–MCP-1 significantly reduced monocyte re-
cruitment to inflamed PLNs (Fig. 2 D). This effect of
MCP-1 inhibition was limited to the GFPMED subset,
whereas anti–MCP-1 did not affect the small number of
GFPHIGH cells that were recovered from inflamed PLNs.
Furthermore, anti–MCP-1 only affected monocyte re-
cruitment to inflamed PLNs; it did not alter the frequency
of GFP  cells in resting PLNs, peripheral blood, or the
spleen nor did it affect the overall cellularity of inflamed
PLNs (data not shown).
It should be emphasized that the small number of homed
monocytes recovered from recipient PLNs reflects the lim-
ited availability of donor monocytes and not inefficient
trafficking (although PBMCs from as many as 50 donors
were pooled for every experiment, each of the two PBMC
recipients received only  500,000 GFP  cells). The mean
Figure 2. Short-term  homing of a doptively
transferred L-selectin CCR2  monocytes to in-
flamed PLNs is mediated by MCP-1. (A) Flow cy-
tometry of PBMCs from CX3CR1 /GFP knockin
mice stained for the monocyte-macrophage mark-
ers F4/80 or CD11b (Mac-1) reveals two popula-
tions of GFP  leukocytes based upon differential
expression of GFP, L-selectin (CD62L), and
CCR2. The F4/80 GFP  cells were identified as
eosinophils by their high side scatter (data not
shown). (B) Flow cytometric analysis of leukocyte
populations in homing assays. CX3CR1 /GFP PB-
MCs were injected intravenously into wild-type
recipients 5–7 d after induction of skin inflamma-
tion by CFA/KLH injection. 4 h later, GFP  do-
nor populations in recipient blood and inflamed
PLNs were compared with input PBMCs. To
avoid counting of contaminating GFP  NK cells,
all samples were stained with anti-NK1.1. Num-
bers in dot plots indicate the percentage of GFP 
cells in the GFPMED and GFPHIGH gates in one rep-
resentative experiment (out of 6). (C) GFPMED cells
(white bars), but not GFPHIGH cells (black bars)
were preferentially recruited to inflamed PLNs.
Data presented as mean   SEM, n   6 mice per
group. **P   0.01 vs. frequency of input GFPMED
CX3CR1 /GFP PBMCs in the input. ##P   0.01
vs. input frequency of GFPHIGH CX3CR1 /GFP
PBMCs. (D) Homing of all GFP  and GFPMED
CX3CR1 /GFP NK1.1   leukocytes to inflamed
subiliac PLNs (black bars) and to contralateral non-
inflamed PLNs (white bars). The inflammation-
induced increased homing of the GFPMED subset was
completely blocked by anti–MCP-1. Anti–MCP-1
treatment did not affect homing of GFPHIGH cells
and did not alter CX3CR1 /GFP NK1.1  cell numbers in recipient blood or spleen (data not shown). Data presented as mean   SEM, n   5 mice per
group. *P   0.05 control mAb inflamed versus contralateral PLNs. #P   0.05 vs. control mAb-treated inflamed PLNs.1366 Chemokine Action by Remote Control
hourly rate of recruitment to inflamed PLNs was 164
GFPMED monocytes for every million GFPMED cells in the
input (Table I). To assess the significance of this result rela-
tive to a cell population with known PLN-tropism, we also
measured the recruitment rate of naive T cells to PLNs us-
ing the same protocol. The hourly rate of T cell recruit-
ment to inflamed PLNs was 7.3 times higher than GFPMED
monocytes. However, adoptively transferred T cells circu-
lated in the recipients’ blood stream at a 2.2-fold higher
concentration than GFPMED monocytes (Table I). When
the rate of recruitment of each subset was normalized to re-
flect equivalent blood levels, naive T cells homed 3.3 times
more efficiently to inflamed PLNs than monocytes. It must
be considered that every recruited monocyte has the po-
tential to exert biological activity upon entering PLNs,
whereas only a minute fraction of homed T cells is likely to
encounter a cognate antigen and become activated. Thus,
the observed rate of monocyte recruitment to inflamed
PLNs is not only quantitatively, but probably also immu-
nologically highly significant.
The low blood concentration of adoptively transferred
monocytes also makes it unlikely that many GFP  cells
were passively trapped in PLN microvessels when tissues
were harvested. Based on previous measurements of mi-
crovascular dimensions and blood flow (21), and the mean
passage time through PLNs of a bolus of 150-kD FITC-
dextran (3.5   1.2 s; n   5), the intranodal blood volume
in a normal subiliac LN can be estimated as  60 nl (un-
published data). Even if one assumes a substantial increase
in the blood content of the enlarged PLNs that drain in-
flamed skin, at a mean blood concentration of 4.4 GFPMED
cells/ l it is unlikely that more than two noninteracting
monocytes were present in the intranodal blood stream at
the time of tissue harvest. Based on these considerations,
we conclude that circulating monocytes are rapidly and ef-
ficiently recruited into PLNs that drain sites of inflamma-
tion, and MCP-1 is an important mediator of this process.
Adoptively Transferred Monocytes Home to Inflamed PLNs
via HEVs. To determine the route by which monocytes
entered PLNs, we removed inflamed subiliac PLNs from
recipients 60 min after injecting CX3CR1 /GFP PBMC
either intravenously or directly into the inflamed flank
skin. Cryosections were stained with anti-PNAd mAb
MECA-79 to identify HEVs, and the position of GFP 
monocytes within the PLN was analyzed by confocal mi-
croscopy (Fig. 3 A). When CX3CR /GFP cells were in-
jected intracutaneously 1 h before tissue harvest, no GFP 
cells could be found in multiple sections of draining PLNs
suggesting that, during this relatively short time interval,
monocytes do not enter afferent lymphatics in substantial
numbers (data not shown). In contrast, after intravenous
injection, numerous GFP  cells were found in inflamed
PLNs. The vast majority of these cells was associated with
HEVs, with 31% of GFP  leukocytes found either within
the lumen or the vessel wall (Fig. 3 B) and 51% located in
the T cell area within 5 cell diameters ( 40  m) of the
closest HEV. Only 3% of all GFP  leukocytes were found
in the subcapsular sinus, the site of entry for leukocytes in
afferent lymph. This HEV-centric distribution of mono-
cytes in PLNs was remarkably similar to that of naive T
cells (unpublished data), which are known to access PLNs
exclusively via HEVs (6–8). We conclude that at least
within the first hour after adoptive transfer monocytes en-
ter inflamed PLNs preferentially via HEVs and not via af-
ferent lymph vessels.
Intracutaneously Injected MCP-1 Is Transported to PLN
HEVs. Previous studies have shown that IL-8,
RANTES, MIP-1 , and SLC can accumulate in draining
PLN HEVs after intracutaneous injection (17, 18). To test
whether skin-derived MCP-1 has a similar fate, we in-
jected recombinant murine MCP-1 (1  g   100 pmol)
into the flank skin of MCP-1 /  mice. 40 min later, MCP-1
protein was detectable by ELISA in the ipsilateral subiliac
LN (45.5   11.5 pg/mg tissue; mean   SEM, n   4), with
Table I. Comparison of Monocyte and Naive T Cell Migration to Resting and Inflamed PLNs
Cell type Monocytes Naive T cells
PLNs Contralateral Inflamed Contralateral Inflamed
Total no. of cells/PLN (  106) 3.43   1.21 10.58   2.10 0.89   0.17 10.31   2.27
Total no. of homed GFPMED cells/PLN 37   18 173   48 1,712   229 19,228   3,837
Recruitment rate
(  h 1   10 6 cells injected)
28.9   12.9 164   53 107   14 1,202   240
GFPMED cells/ l blood 4.4   0.7 9.7   2.1
Comparison of T cell and monocyte recruitment efficiency to resting and inflamed PLNs. Recipient mice with unilateral flank skin inflammation
(5–7 d) were injected with 5   106 donor cells from either CX3CR /GFP mice (PBMCs containing  10% GFP  cells, half of which were GFPMED
monocytes) or T-GFP mice (LN cells containing  80% GFP+ naive T cells). Peripheral blood and the subiliac LNs contralateral and ipsilateral to the
inflamed tissue were harvested 4 h later and analyzed for the presence of GFP  cells and the rate of cell recruitment was calculated. In animals that
received CX3CR /GFP cells the frequency and rate of recruitment were also determined for the GFPMED subset (shown in parenthesis). Data are shown
as mean   SEM of five experiments in each group.1367 Palframan et al.
limited spillover into the contralateral subiliac LN (5.5  
0.3 pg/mg tissue).
While these results established that MCP-1, like other
chemokines, is transported from the periphery to draining
PLNs, it remained to be determined whether MCP-1 is
targeted to HEVs. Two approaches were taken to address
this question: first, using autoradiography and immunohis-
tochemistry of draining PLNs, we observed that intracuta-
neously injected 125I-labeled human MCP-1 was highly
concentrated in MECA-79  HEV (Fig. 4 A); second, using
intravital fluorescence microscopy of subiliac PLNs in mice
that were injected 40 min earlier with fluorescent hMCP-
1ALEXA, we detected hMCP-1ALEXA exclusively in HEVs,
but not in arterioles or capillaries (Fig. 4 B and C).
Intracutaneous Injection of MCP-1 Reconstitutes Monocyte
Homing to Inflamed PLNs in MCP-1 /  Mice. To deter-
mine whether skin-derived MCP-1 is sufficient to stimu-
late monocyte homing to PLNs upon presentation in
HEVs, CX3CR1 /GFP PBMCs were injected into MCP-
1 /  mice 5 d after induction of skin inflammation in both
flanks and the right lateral chest region. 10 min before
adoptive transfer, the left inflamed flank skin was injected
with 25  g MCP-1, while the two inflamed contralateral
regions were injected with vehicle (PBS). Homed GFP 
cells were quantitated in each PLN 90 min later. In three
experiments thus performed, the frequency of GFPMED
cells in the left subiliac PLN that received MCP-1 via affer-
ent lymph was 47 and 193% higher than in the contralateral
subiliac and brachial PLNs, respectively (Fig. 5 A and B).
In contrast, the mean frequency of GFPHIGH cells, which
do not respond to MCP-1, was similar in all PLNs. This
finding and the fact that GFPHIGH cells occurred at equiva-
lent frequency in the recipients’ blood as GFPMED cells
(Fig. 5 A) indicates that the observed difference in the ac-
cumulation of GFPMED cells was a direct consequence of
MCP-1 injection and cannot be explained by differential
hemodynamics or tissue contamination with blood.
After injection of 25  g recombinant MCP-1 in the left
flank some intracutaneously injected chemokine was found
in the contralateral subiliac LN and, to a lesser degree, the
brachial LN (Fig. 5 C). When tissues were harvested from
MCP-1 /  mice 90 min after intracutaneous injection, op-
tical density measurements in our ELISA assay were at least
10-fold higher in PLNs of MCP-1 recipients than in PLNs
of a MCP-1 /  mouse that was not injected with chemo-
kine (data not shown). This chemokine “spillover” is con-
sistent with earlier experiments with SLC (17) and the ex-
periments described previously using a lower dose (1  g) of
MCP-1. Thus, it seems plausible that some monocytes that
homed to the contralateral subiliac and brachial PLNs were
recruited by MCP-1 that was transported there from the
injection site. Despite this, the number of monocytes in the
Figure 3. Monocytes home to inflamed PLNs via HEVs. Adoptive transfer of
CX3CR1 /GFP PBMCs into wild-type recipients was performed 5 d after induction of
skin inflammation as described in Fig. 2. Draining PLNs were removed after 1 h and pre-
pared for confocal microscopy using appropriate filters for detection of GFP  monocytes
(green) and HEVs, which were visualized using anti-PNAd mAb MECA-79 and Cy5-
labeled anti–rat IgM (red). (A) Representative confocal micrographs of homed GFP 
monocytes in close proximity to MECA-79  HEVs. (B) The frequency distribution of
homed GFP  monocytes relative to MECA-79  HEVs and the subcapsular sinus was
determined. Data are expressed as mean   SEM of the percentage of GFP  cells in each
class. n   90 random sections of five inflamed PLNs from two independent experiments.1368 Chemokine Action by Remote Control
right brachial LN was significantly smaller than in the
MCP-1 draining left subiliac LN (P   0.03), whereas in-
termediate monocyte numbers were present in the con-
tralateral subiliac LN (P   0.05 vs. right brachial and left
subiliac LNs). Thus, homing of GFPMED (but not GFPHIGH)
cells to recipient PLNs correlated with the presence of
MCP-1 indicating that remotely-administered MCP-1
stimulates monocyte recruitment into draining PLNs of
MCP-1 /  mice.
MCP-1 Induces Arrest of Rolling Monocytes in Inflamed
PLN HEVs. As shown above, intracutaneously injected
MCP-1 is quickly translocated to HEVs, which we identi-
fied as a port of MCP-1–dependent monocyte entry from
the blood. Thus, it seemed likely that MCP-1 acted di-
rectly on monocytes within HEVs. To test this hypothesis,
we performed intravital microscopy in subiliac PLNs (21).
We used the murine monocytoid WEHI78/24 cell line,
which has previously been shown to adhere to inflamed
but not resting PLN HEVs in a Stamper–Woodruff assay
(9). WEHI78/24 cells are L-selectin  and respond avidly to
MCP-1 (EC50   1 nM), but not to SLC in chemotaxis as-
says (data not shown).
Rolling fractions of WEHI78/24 monocytes were similar
in inflamed and resting PLNs of both wild-type and MCP-
1 /  mice (Fig. 6 A and B). However, rolling WEHI78/24
cells arrested significantly more frequently in inflamed PLNs
of wild-type mice compared with noninflamed wild-type
PLNs or inflamed PLNs in MCP-1 /  mice (Fig. 6 C and
D). Both rolling and sticking was more frequent in paracor-
tical high order branches of the venular tree (Fig. 6 A and
C), as shown previously for lymphocytes (21, 29). Impor-
tantly, injection of MCP-1 into inflamed skin of MCP-1 / 
mice restored the ability of rolling monocytes to stick in
high order HEVs of the draining PLN.
While these findings are consistent with a scenario where
luminal MCP-1 in HEVs triggers integrin-mediated stick-
ing by signaling through CCR2 on rolling monocytes,
these data did not exclude the possibility that MCP-1 acted
indirectly by triggering the release of other integrin activat-
ing mediator(s). Therefore, we investigated the effect of
CCR2 inhibition on WEHI78/24 cell behavior in in-
flamed PLNs. Since neutralizing reagents to murine CCR2
were not available, we incubated WEHI78/24 cells for 40
min with 500 nM MCP-1 because chemokine receptors,
including CCR2, can be effectively desensitized by pro-
longed exposure to high concentrations of their specific
ligand (references 17 and 30, and data not shown). When
MCP-1 desensitized WEHI78/24 cells were analyzed in
inflamed PLNs of MCP-1 /  mice injected intracutane-
ously with MCP-1, they rolled normally, but displayed a
significantly reduced ability to arrest (Fig. 6 E). In contrast,
rolling and sticking were not affected by desensitization to
MIP-1 , an agonist on CCR1 and CCR5 to which
WEHI78/24 cells are highly responsive in chemotaxis as-
says (data not shown). These results strongly support the
concept that MCP-1 acts directly on rolling monocytes to
stimulate arrest, most likely by signaling through CCR2.
Discussion
Here we show that inflamed cutaneous tissues discharge
MCP-1 into the lymph, which is crucial for the recruit-
ment of monocytes/macrophages in HEVs of draining
Figure 4. MCP-1 accumulates in HEVs after intracutaneous injection.
(A) Draining PLNs were harvested from a mouse 1 h after intracutaneous
injection of 125I-MCP-1. Sections were stained with anti-PNAd mAb
MECA-79 (red) and hematoxylin (blue) and used to generate autoradio-
graphs to localize radiolabeled chemokine (visible as dark grains). (B and
C) Intravital micrographs of a draining PLN in an anesthetized mouse  1 h
after intracutaneous injection of hMCP-1ALEXA. (B) Fluorescent MCP-1
was observed only in HEVs, but not in arterioles (art), whereas (C) the
plasma marker FITC-dextran (150 kD) filled the entire microvasculature.1369 Palframan et al.
PLNs. Using an experimental model of CFA/KLH-
induced inflammation, we found that long-term accumula-
tion of endogenous mononuclear phagocytes and short-
term homing of adoptively transferred blood monocytes in
draining PLNs was impaired in MCP-1 /  mice and in
wild-type mice treated with anti–MCP-1. MCP-1 tran-
scription occurred primarily in inflamed skin from where
MCP-1 protein was rapidly transported to draining PLNs
and accumulated in HEVs. Upon presentation in the HEV
lumen, skin-derived MCP-1 triggered the arrest of rolling
monocytes. These observations establish a novel mode of
leukocyte trafficking by “remote control” where chemo-
kines exert effects in an organ that is distant to the tissue of
their production.
Data from our homing experiments with CX3CR /GFP
PBMCs suggest that monocyte recruitment via HEVs was
remarkably efficient (Table I): the concentration of the
GFPMED monocyte population in recipient blood was  4.4
cells/ l; total blood flow in subiliac LNs has been esti-
mated as  1  l/min (21); on average, 173 homed GFPMED
cells were recovered from inflamed PLNs 4 h after transfer
(Fig. 2 C); this suggests that about one-sixth of all mono-
cytes that entered PLN HEVs were successfully recruited.
If one assumes that murine blood contains  100 endoge-
nous monocytes per  l (31), this rate of recruitment would
result in a daily influx of  23,000 cells into each inflamed
PLN. Considering the number of CD11b F4/80  cells re-
covered from inflamed subiliac LNs (Fig. 1 A), it seems
likely that a substantial fraction of these cells entered the
PLNs via HEVs, while the remainder may have arrived via
afferent lymphatics and/or proliferated locally.
This mechanism may have evolved to support two major
physiologic functions of PLNs: (a) the collection and pre-
sentation of peripheral antigens to lymphocytes; and (b) the
filtration and clearance of lymph fluid from peripheral tis-
sues. While the former has long been the subject of intense
study, the latter has received relatively little attention.
However, some pathogens that penetrate the skin can ex-
ploit the lymphatics as a major conduit for systemic dissem-
ination. A point in case is Yersinia pestis, arguably the most
devastating bacterial pathogen in human history (32). Dur-
ing bubonic plague, Y. pestis is deposited in the skin, typi-
cally by a flea bite, enters afferent lymph vessels and prolif-
erates rapidly in draining PLNs. Interestingly, Y. pestis
infection is associated with minimal recruitment of myeloid
phagocytes in afflicted PLNs, whereas less virulent Yersinia
strains elicit a more potent inflammatory response (33). In
addition to other documented effects of Y. pestis on phago-
cyte function (34), it is tempting to speculate that the un-
precedented success of this mammalian pathogen was due
in part to interference with phagocyte recruitment to PLNs
possibly by subverting the production or transportation of
chemokines such as MCP-1 and/or by disabling phagocyte
responsiveness to them.
While neutralization of microorganisms that enter PLNs
from the periphery is a likely purpose of newly recruited
monocytes, their ultimate fate and function are undeter-
mined. Monocytes may further differentiate depending on
the cytokine milieu (which may also be modulated by
lymph-borne mediators). After the key diapedesis step (35),
exposure to IL-4, GM-CSF, and other signals drives DC
differentiation (3, 36), whereas IL-6 and M-CSF stimulate
macrophage generation (37). Macrophages fulfill multiple
functions in PLNs: they scavenge particulates from afferent
lymph (38); maintain the phenotype of HEV (2, 39); pro-
duce angiogenic factors (40); and generate lymphotropic
Figure 5. Intracutaneous injection of re-
combinant MCP-1 into MCP-1 /  mice
enhances monocyte homing in draining
PLNs. MCP-1 /  mice with cutaneous in-
flammation in both flanks and the right lat-
eral chest were injected intracutaneously
with recombinant murine MCP-1 (25  g)
over the left flank and vehicle (50  l PBS)
elsewhere, as described in Materials and
Methods. 10 min later, 1.5   107
CX3CR1 /GFP donor PBMCs (containing
 106 GFP  cells) were injected intrave-
nously. (A) FACS® plots show the fre-
quency of GFP NK1.1  monocytes after
90 min in recipient blood, the PLN drain-
ing MCP-1–injected skin (subiliac LN plus
MCP-1), the contralateral subiliac LNs
(subiliac LN plus vehicle), and the inflamed
brachial LN (brachial LN plus vehicle) from
the same mouse. 6   105 events are plotted
in each histogram. (B) GFPMED, but not
GFPHIGH CX3CR /GFP cells accumulate
preferentially in the subiliac LN that
drained the MCP-1 injection site. Mean  
SEM of three separate experiments are
shown. (C) MCP-1 protein concentration
in inflamed left and right subiliac LNs and right brachial LNs 90 min after intracutaneous injection of recombinant murine MCP-1 or vehicle. Each
curve reflects MCP-1 concentration in three PLNs measured in the same mouse.1370 Chemokine Action by Remote Control
cytokines and chemokines. Indeed, it has been proposed
that impaired monocyte/macrophage migration is responsi-
ble for the reduced Th1 cytokine production in PLNs of
immunized CCR2 /  mice (41, 42).
The possibility that newly recruited monocytes in
PLNs differentiate into DCs is particularly appealing.
Most previous work has focused on afferent lymph as the
primary route of DCs entry into PLNs (1, 3–5). Lymph-
borne DCs that enter PLNs from inflamed tissues acquire
a mature phenotype en route and lose their endocytic
ability, preventing them from acquiring more antigen
should they encounter it in draining PLNs (3). We pro-
vide evidence that monocytes, the precursors of myeloid
DCs, can enter PLNs directly from the blood. These cells
should be fully capable of antigen acquisition, processing,
and differentiation into DCs given the appropriate cyto-
kine stimuli.
Hendricks et. al. have reported that ligation of afferent
lymphatic vessels blocks macrophage accumulation in in-
flamed PLNs (2). This was assumed to be caused by ob-
structed macrophage traffic through afferent lymphatics.
Our homing and confocal microscopy experiments show
that monocytes can be directly recruited via HEVs. Re-
motely administered MCP-1 stimulated circulating mono-
cyte homing to draining PLNs of MCP-1 /  mice. Thus,
in addition to blocking macrophage transport from periph-
eral tissues, ligation of afferent lymphatics might indirectly
block monocyte recruitment mediated by remotely gener-
ated chemoattractants in HEVs. Occlusion of afferent lym-
phatics also leads to loss of luminal expression of the L-selec-
tin ligand, PNAd (39), which might further disrupt
monocyte recruitment via HEVs.
PNAd is highly expressed in resting and inflamed PLN
HEVs (43) and mediates tethering and rolling of L-selec-
Figure 6. MCP-1 triggers the arrest of
rolling monocytes in PLN HEVs. Adhesive
behavior of WEHI78/24 cells in venular
trees of subiliac PLNs was analyzed by intra-
vital microscopy. Experiments were per-
formed in wild-type mice draining either
normal (white bars) or inflamed skin (black
bars) and in inflamed PLNs of MCP-1 / 
mice that were either untreated (hatched
bars) or injected intracutaneously with
MCP-1 (cross-hatched bars). Rolling frac-
tions (percentage of total cells passing
through a given venule which interact with
the vessel wall) and sticking fractions (per-
centage of rolling cells which arrest for  30 s)
are shown in each branching order of the
venular tree (A and C) and as the mean for
all venules (B and D). Mean   SEM; total
number of animals/venules analyzed are
shown in B and D. (E) Desensitization of
WEHI78/24 cells to MCP-1, but not
MIP-1  inhibits arrest in inflamed PLN
HEVs. WEHI78/24 cells were incubated
for 40 min with MIP-1  (500 nM) or
MCP-1 (500 nM). Desensitized WEHI78/
24 cells were injected into MCP-1 / 
mice, which had been pretreated 7 d and
40 min earlier with intracutaneous injec-
tions of CFA/KLH and 100 pmol MCP-1,
respectively. Mean rolling and sticking
fractions in 21 HEVs (13 order IV and 8
order V) in three mice are shown for each
group. **P   0.01.1371 Palframan et al.
tin  leukocytes (21, 29). L-selectin binding to PNAd is the
essential first step for lymphocyte homing to PLNs (44, 45).
This pathway mediates also monocyte adhesion to PLN
HEVs in vitro (9). Accordingly, in our homing experi-
ments with CX3CR1 /GFP PBMCs, only the L-selectin 
GFPMED subset was efficiently recruited to PLNs, consis-
tent with a key role for L-selectin in this setting. The re-
quirement for L-selectin can explain why effector T cells,
which are typically L-selectin , home poorly to PLNs,
even though a sizeable fraction of these cells can respond to
MCP-1 and other inflammatory chemokines that may be
presented in inflamed HEVs (7, 46, 47). However, while
leukocyte adhesion in PLN HEVs must be initiated by
L-selectin, this pathway mediates only rolling which must
be followed by an activating stimulus that triggers integrin
mediated arrest. Rolling T cells respond to the CCR7 ago-
nist SLC in PLN HEVs to engage the  2 integrin LFA-1
(17), but blood monocytes do not respond to CCR7 ago-
nists (48, 49). Thus, another activating stimulus is necessary
for monocyte arrest in HEVs.
Our intravital microscopy analysis has uncovered several
lines of evidence that MCP-1 provides this stimulus: (a)
both monocyte sticking and the concentration of MCP-1
were increased in inflamed versus resting PLNs; (b) arrest
of rolling monocytes was impaired in inflamed PLNs of
MCP-1 /  mice; (c) sticking in MCP-1 /  PLNs was re-
stored after intracutaneous injection of MCP-1; and (d)
monocyte desensitization to MCP-1–inhibited sticking.
MCP-1 probably exerted its effects via CCR2 signaling
leading to integrin activation. In vitro studies have shown
that MCP-1 can activate the  4 1 integrin on human
monocytes and T cells (50). WEHI78/24 cells adhered to
HEVs, in part, via LFA-1 and Mac-1 in tissue sections of
inflamed, but not resting PLNs (9). On the other hand, in-
hibition of  4 and  2 integrins had little effect on MCP-1–
mediated monocyte arrest on virally transduced endothe-
lium in a flow chamber (11), and MCP-1 stimulated T cell
adhesion only to extracellular matrix molecules, but not to
the purified integrin ligands intracellular adhesion molecule
1 or vascular cell adhesion molecule 1 (51). Thus, it re-
mains to be determined which adhesion molecules are re-
sponsible for MCP-1–induced monocyte arrest in HEVs.
Even though the participation of MCP-1 in the three-
step adhesion cascade in HEVs is clearly a major mecha-
nism for monocyte recruitment to inflamed PLNs, our data
do not rule out other functions for MCP-1, e.g., during
transendothelial or interstitial migration. It is also possible
that additional endothelial conditioning by inflammatory
signals is necessary for monocyte recruitment that may be
independent of or indirectly induced by the action of
MCP-1. Furthermore, although nearly all GFP  cells in
frozen sections were found in the vicinity of HEVs in our
confocal microscopy analysis (Fig. 3), this does not exclude
that MCP-1 is also involved in monocyte recruitment into
inflamed skin from where cells may reach draining PLNs
after some delay. Whatever additional effects MCP-1 may
have, this study demonstrates that changes in the local che-
mokine milieu in inflamed peripheral tissues are readily
projected onto the microvasculature of draining PLNs. By
using autoradiography and intravital microscopy, we ob-
served that radiolabeled and fluorescent MCP-1 injected
into the skin was rapidly and selectively transported to
HEVs in draining PLNs, with very little protein detected in
other PLNs. Even though our ELISA data of tissue lysates
showed that the concentration of MCP-1 protein in drain-
ing PLNs was lower than in inflamed skin, this difference
may not be reflected at the level of the endothelium be-
cause MCP-1 was highly concentrated in HEVs, with min-
imal signal in extravascular sites.
It has recently been shown how lymph-borne chemo-
kines gain access to HEVs in draining PLNs (18). Upon en-
tering the subcapsular sinus, chemokines are channeled
along collagen fibers in the FRC network, which forms a
conduit from the subcapsular sinus to HEVs (52). To in-
duce the arrest of rolling monocytes, MCP-1 must reach
the luminal surface of HEVs. This is possibly achieved by
transcytosis as described in skin postcapillary venules for IL-8
and RANTES (53). There also appears to be a physical
barrier preventing lymph-borne chemokines from diffusing
into the T and B cell area, thus spatially restricting chemo-
kine action and preventing disruption of the PLN mi-
croenvironment (18). The architecture of the FRC conduit
and the physical limitations on chemokine diffusion can
explain how intracutaneously injected chemokines are se-
lectively targeted to HEVs, and not to arterioles or capillar-
ies (reference 17, and this study). This anatomical arrange-
ment might also channel immunogens, microbial products,
and cytokines to HEVs. The resulting juxtaposition of em-
igrating monocytes, soluble antigens, and lymph-borne cy-
tokines would provide a mechanism by which antigen can
be rapidly acquired and processed.
In conclusion, we show that during cutaneous inflam-
mation monocyte homing into draining PLNs is mediated
by skin-derived MCP-1. This effect may have evolved as a
host response to cutaneous infection to allow rapid stock-
ing of draining PLNs with leukocytes innately possessing a
high phagocytic activity and plasticity for further differenti-
ation. As macrophages, monocytes limit the spread of in-
fections, and as DCs they have the ability to process and
present antigen to stimulate a vigorous adaptive immune
response. To what extent homed monocytes assume such
vital functions in inflamed PLNs will require further inves-
tigation. The present data suggest that inflamed peripheral
tissues can remotely control the recruitment of monocytes
and possibly their further differentiation in draining PLNs
by releasing chemokines into the lymph. We propose that
similar mechanisms may also shape the composition of
other leukocyte populations that get recruited to PLNs.
Thus, afferent lymphatics are not only a pipeline for drain-
age of interstitial fluid and the delivery of antigen from the
periphery, but also a one-way communication link by
which peripheral tissues may shape immune responses in
draining PLNs.
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